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Abstract
Evidence for associations between long-term protein intake with mortality is not consistent. We aimed to examine associa-
tions of dietary protein from different sources with all-cause and cause-specific mortality. We followed 7786 participants 
from three sub-cohorts of the Rotterdam Study, a population-based cohort in the Netherlands. Dietary data were collected 
using food-frequency questionnaires at baseline (1989–1993, 2000–2001, 2006–2008). Deaths were followed until 2018. 
Associations were examined using Cox regression. Additionally, we performed a highest versus lowest meta-analysis 
and a dose–response meta-analysis to summarize results from the Rotterdam Study and previous prospective cohorts. 
During a median follow-up of 13.0 years, 3589 deaths were documented in the Rotterdam Study. In this cohort, after 
multivariable adjustment, higher total protein intake was associated with higher all-cause mortality [e.g. highest versus 
lowest quartile of total protein intake as percentage of energy (Q4 versus Q1), HR = 1.12 (1.01, 1.25)]; mainly explained 
by higher animal protein intake and CVD mortality [Q4 versus Q1, CVD mortality: 1.28 (1.03, 1.60)]. The association of 
animal protein intake and CVD was mainly contributed to by protein from meat and dairy. Total plant protein intake was 
not associated with all-cause or cause-specific mortality, mainly explained by null associations for protein from grains 
and potatoes; but higher intake of protein from legumes, nuts, vegetables, and fruits was associated with lower risk of 
all-cause and cause-specific mortality. Findings for total and animal protein intake were corroborated in a meta-analysis 
of eleven prospective cohort studies including the Rotterdam Study (total 64,306 deaths among 350,452 participants): 
higher total protein intake was associated with higher all-cause mortality [pooled RR for highest versus lowest quantile 
1.05 (1.01, 1.10)]; and for dose–response per 5 energy percent (E%) increment, 1.02 (1.004, 1.04); again mainly driven by 
an association between animal protein and CVD mortality [highest versus lowest, 1.09 (1.01, 1.18); per 5 E% increment, 
1.05 (1.02, 1.09)]. Furthermore, in the meta-analysis a higher plant protein intake was associated with lower all-cause 
and CVD mortality [e.g. for all-cause mortality, highest versus lowest, 0.93 (0.87, 0.99); per 5 E% increment, 0.87 (0.78, 
0.98), for CVD mortality, highest versus lowest 0.86 (0.73, 1.00)]. Evidence from prospective cohort studies to date sug-
gests that total protein intake is positively associated with all-cause mortality, mainly driven by a harmful association of 
animal protein with CVD mortality. Plant protein intake is inversely associated with all-cause and CVD mortality. Our 
findings support current dietary recommendations to increase intake of plant protein in place of animal protein.
Clinical trial registry number and website NTR6831, https ://www.trial regis ter.nl/trial /6645
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Introduction
Defining the role of dietary protein intake in health has 
been a long-standing research topic of interest and remains 
a high priority in nutrition research. Although protein 
delivers amino acids that are crucial for various body 
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functions, protein intake in the general population tends to 
be much higher than required [1]. Short-term randomized 
clinical trials have suggested that consumption of high-
protein diets may favor weight management and improve 
blood lipid and lipoprotein profiles and glycemic regulation 
[2–4]. However, several prospective observational studies 
have reported that long-term high intake of total protein 
and protein from animal-based food sources is associated 
with higher risk of type 2 diabetes [5] and cardiovascular 
diseases (CVD) [6].
Recently, to further explore the role of habitual dietary 
protein intake in overall health, several previous epide-
miological prospective cohort studies have examined the 
associations between protein intake and all-cause and 
cause-specific mortality [7–15]. Although generally point-
ing towards harmful or null associations for animal protein 
and beneficial or null associations for plant protein, the 
results are not entirely consistent. For example, Song et al. 
observed in the Nurse Health Study and the Health Profes-
sionals Follow-Up Study that higher animal protein intake 
was associated with higher CVD mortality risk, while 
higher plant protein intake was associated with lower risk 
of all-cause and CVD mortality [11]. In contrast, Kelemen 
et al. [8] and Budhathoki et al. [16], reported null asso-
ciations of total and animal protein with risk of all-cause 
and CVD mortality and beneficial association of plant 
protein with CVD mortality in the Iowa Women’s Health 
Study and the Japan Public Health Center-based Prospec-
tive Cohort, respectively. And Tharrey et al. observed that 
higher animal protein intake was associated with higher 
CVD mortality, but plant protein intake was not associ-
ated with CVD mortality in the Adventist Health Study-2 
[14]. Furthermore, evidence for protein intake from more 
specific animal food sources (e.g. protein from meat and 
dairy) and plant food sources (e.g. protein from legumes, 
nuts, and grains) and mortality, which may partly explain 
the inconsistencies in the previous studies is more limited 
[11] and remains to be further clarified. Moreover, to date 
no meta-analysis that summarizes associations between 
protein intake and mortality has been published.
Therefore, we aimed to investigate the associations of 
total protein intake and protein from different food sources 
with all-cause and cause-specific mortality in the Rotter-
dam Study. Also, to further clarify the current evidence 
from previous studies, we systematically reviewed and 
meta-analyzed our findings with those from previous pro-
spective studies to evaluate the association of dietary pro-
tein intake with mortality.
Methods
The current study consisted of two stages. First, we ana-
lyzed the associations of protein intake with all-cause 
and cause-specific mortality in the Rotterdam study. Sec-
ond, we conducted a systematic review and meta-analysis 
by combining the new results from the Rotterdam Study 
with results from previous prospective cohort studies.
Methods for the Rotterdam Study analyses
Study design and population in the Rotterdam Study
The first stage of this study was conducted within the Rot-
terdam study, a prospective cohort study of participants 
aged 45 years and above in Rotterdam, the Netherlands 
[17]. Briefly, the Rotterdam Study currently consists of 
three sub-cohorts available. The first sub-cohort of the 
Rotterdam Study (RS-I) was initiated in the period of 
1989–1993 by recruiting participants aged ≥ 55 years 
from the district of Ommoord (n = 7983). In 2000–2001, 
the study was extended with a second sub-cohort (RS-II) 
including new individuals who had become 55 years of 
age or moved into the study area (n = 3011). In 2006-08, 
a third sub-cohort (RS-III) was started of new individu-
als aged 45 years and older (n = 3932). Until the end of 
2008, 14,926 participants were contained in the three 
sub-cohorts at baseline. Information every 3–5 years was 
collected through interviews, for which the participants 
were visited at their homes, through questionnaires which 
the participants returned, and through examinations in 
our dedicated research center which is in the Ommoord 
district. In the home interviews, we collected informa-
tion such as education level, smoking status, and medical 
history. At the examination center, we mainly focused on 
examinations of imaging (of heart, blood vessels, eyes, 
skeleton, and brain) and on collecting biospecimens that 
enabled further in-depth molecular and genetic analysis. 
The Rotterdam Study has been approved by the insti-
tutional review board (Medical Ethics Committee) of 
Erasmus Medical Center and by the review board of The 
Netherlands Ministry of Health, Welfare and Sports. The 
approval has been renewed every 5 years. All participants 
gave informed consent [17].
For the current analysis within the Rotterdam Study, 
of the 14,926 participants who participated at baseline, 
we had dietary data available for 9701. Main reasons for 
absence of valid dietary data among the 5225 participants 
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were: no dietary data available (n = 4890) including not 
having received dietary assessment because of logistic 
reasons, living in a resident home for elderly or suspected 
dementia, and not having completed the dietary assess-
ment; or excluded as invalid dietary data (n = 335) defined 
as an estimated energy intake of < 500 or > 5000 kcal/day) 
[18, 19]. From these 9701 participants, we further excluded 
1914 participants with CVD, diabetes, or cancer at base-
line, and 1 participant without follow-up data on mortality, 
leaving 7786 participants for the main analyses (Supple-
mental Figure 1).
Dietary assessment
Dietary intake in the Rotterdam Study was assessed at base-
line in all three sub-cohorts using a semi-quantitative food 
questionnaire (FFQ) as described in more details elsewhere 
[19, 20]. Briefly, we used an FFQ with 170 food items 
to assess dietary intake at baseline of RS-I (1989–1993) 
and at baseline of RS-II (2000–2001). This 170-item FFQ 
was validated against fifteen 24-h food records and four 
24-h urinary urea excretion samples which were collected 
on non-consecutive days over a period of a year in a sub-
sample of the Rotterdam Study (n = 80) [21]. Adjusted 
Pearson’s correlation coefficients between protein intake 
measured with the FFQ and protein measured with the food 
records were 0.66 for total protein intake, and 0.59 for plant 
protein intake; and Spearman’s correlation between protein 
measured with the FFQ and protein measured from urinary 
urea was 0.67 for total protein intake. Further details are 
provided in the study by Klipstein-Grobusch et al. [22]. A 
389-item FFQ was used to assess dietary intake at base-
line of RS-III (2006–2008). This 389-item FFQ was pre-
viously validated in two other Dutch populations using a 
9-day dietary record [22] and a 4-week dietary history [23]. 
Pearson’s correlations for intakes of different nutrients var-
ied from 0.40 to 0.86. Food intake data were converted 
to energy and nutrient intake based on the Dutch Food 
Composition tables via which 2152 foods the data on 133 
nutrients can be viewed.
Ascertainment of death
Information on vital status of the participants was obtained 
from clinical follow-up data collection and from munici-
pal records. General practitioners reported events of inter-
est by means of a computerized system or notified new 
events annually. Trained research assistants subsequently 
collected information from medical records at the general 
practitioners’ offices, hospitals and nursing homes. Two 
research physicians independently identified the events 
according to the International Classification of Diseases, 
Tenth revision (ICD-10). Afterwards, a senior physician 
reviewed all coded events. Cause-specific mortality was 
recoded according to the ICD-10 codes (CVD cause: F01, 
I05-99 (non-stroke CVD cause: I05-51, 70-99, stroke 
cause: F01, I60-69.8); cancer cause: C01-97). Coded infor-
mation on all-cause mortality was available until May 2018 
and coded information on cause-specific mortality was 
available until January 2015.
Covariates
Information on age, sex, smoking status, and education 
level was obtained from questionnaires at baseline. Infor-
mation on physical activity was obtained using the adapted 
version of the Zutphen Physical Activity Questionnaire at 
the third visit of RS-I (1997-99) and at baseline of RS-II, 
and the LASA Physical Activity Questionnaire at baseline 
of RS-III. Physical activities were weighted according to 
intensity with Metabolic Equivalent of Task (MET), from 
the Compendium of Physical Activities version 2011. To 
account for differences between the two questionnaires, 
questionnaire-specific z-scores of MET-hours per week 
were calculated. We measured body weight and height at 
baseline in our research center and body mass index (BMI) 
was calculated. A previously defined diet quality score was 
calculated to reflect adherence to Dutch dietary guidelines 
as described in detail elsewhere [20]. Briefly, this was a 
sum-score of the adherence to guidelines for 14 items, 
including: vegetables (≥ 200 g/day), fruit (≥ 200 g/day), 
whole-grains (≥ 90 g/day), legumes (≥ 135 g/week), nuts 
(≥ 15 g/day), dairy (≥ 350 g/day), fish (≥ 100 g/week), tea 
(≥ 450 mL/day), ratio whole-grains: total grains (≥ 50%), 
ratio unsaturated fats and oils: total fats (≥ 50%), red and 
processed meat (< 300 g/week), sugar-containing bever-
ages (≤ 150 mL/day), alcohol (≤ 10 g/day) and salt (≤ 6 g/
day). We scored every participant as adhering to this item 
(‘yes’ scored as 1) or not adhering to the item (‘no’ scored 
as 0). The total diet quality score theoretically ranged from 
0 (no adherence) through 14 (full adherence). We previ-
ously reported that a higher score was associated with a 
lower premature mortality risk and a lower risk of devel-
oping some of the chronic diseases on which the guide-
lines were based [20]. Information on CVD, diabetes, and 
cancers was obtained from general practitioners, pharma-
cies’ datasets, Nationwide Medical Register, or follow-up 
examinations in our research center.
Data analyses
We expressed intake of dietary protein and other macro-
nutrients as a percentage of total energy consumption. 
Baseline characteristics of the Rotterdam population are 
presented for the whole group and by quartiles of total, ani-
mal, or plant protein intake. Trends of these characteristics 
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across quartiles of protein intake were examined by using 
means and linear regression for continuous variables, or 
Chi square tests for categorical variables. After confirm-
ing that the assumption for proportional hazards was met 
on the basis of Schoenfeld residuals [24] and Martingales 
residuals [25], we used Cox proportional hazard models 
to analyze associations of dietary protein intake with all-
cause and cause-specific mortality. Non-linearity of asso-
ciations of protein intake with all outcomes were explored 
using natural cubic splines (degrees of freedom = 3). 
Because effects of macronutrient intake cannot be sepa-
rated from the effects of overall energy intake or intake of 
other macronutrients, we modelled macronutrient substitu-
tion effects. For our main models, we used multivariable 
nutrient density substitution models for protein intake at 
the expense of carbohydrate. For this aim, models were 
used with adjustment for total energy intake and percentage 
of energy from subtypes of fats (saturated fat (SFA), mono-
unsaturated fat (MUFA), polyunsaturated fat (PUFA), and 
trans-fat (TSF)), and from alcohol [26]. Therefore, coeffi-
cients from these models were interpreted as the estimated 
effects of substituting a certain percentage of energy from 
protein intake for equivalent energy from carbohydrate 
intake. We estimated hazard ratios (HRs) and their 95% 
confidence intervals (CIs) of mortality by comparing par-
ticipants in each quartile of protein intake as percentage 
of energy with those in the lowest quartile. To quantify a 
linear trend, we assigned the median within each quartile 
and modeled this variable continuously. Furthermore, we 
also modelled dietary protein intake as continuous variable 
and estimated HRs and 95%CIs per 5 energy percent (E%) 
increment from protein at the expense of carbohydrate.
For all main analyses, we included intake of protein, 
SFA, MUFA, PUFA, TSF, total energy, alcohol, base-
line age, sex, and RS-cohort in model 1; we additionally 
adjusted for smoking status, education level, overall diet 
quality score, fiber intake, physical activity, and BMI in 
model 2. For analysis of animal and plant protein intake, 
mutual adjustment for plant and animal protein was 
performed.
Additional analyses
We further examined if the associations of animal protein 
intake and plant protein intake with all-cause and cause-
specific mortality differed by protein from specific animal 
and plant food sources, such as protein from meat, dairy, 
fish, and eggs, and protein from grains, potatoes, legumes, 
nuts, vegetables, and fruits. In this modelling approach, 
protein from meat, dairy, fish and eggs was entered in 
model per 5 E%, and protein from grains, potatoes, and 
legumes, nuts, vegetables, and fruits were entered in model 
per 3 E%. The percentages of energy intake from protein 
from meat, dairy, fish, and eggs and protein from grains, 
potatoes, and legumes, nuts, vegetables, and fruits were 
simultaneously included in one model, with adjustment for 
all other covariates in model 2.
Sensitivity analyses
We conducted a series of sensitivity analyses to test robust-
ness of our main results. First, we replaced fat intake by 
carbohydrate in the main models (model 2), to examine 
whether it made a difference if dietary protein was con-
sumed at the expense of fat instead of carbohydrate. Sec-
ond, we examined the interaction effect of total, animal, or 
plant protein with age, sex, BMI, or physical activity by 
including their interaction terms in main models (model 2), 
to explore whether the associations of protein intake and 
mortality differed by these factors. Third, we adjusted for 
the modified diet quality score without main protein food 
sources (e.g. without red and processed meat, fish, and leg-
umes) in the analyses. Last, to minimize reverse causality 
bias, we excluded the participants who died within the first 
2 years of follow-up in the Rotterdam study.
We performed all analyses based on combined data from 
RS-I, RS-II, and RS-III. All variables included in analyses 
were used to predict missingness patterns. Missing values 
on covariates were assumed to be missing at random and 
accounted for using multiple imputations (m = 10 imputa-
tions) [27]. Supplemental Table 1 shows the percentage of 
missing data for covariates in the Rotterdam Study. Statisti-
cal procedures were performed with the use of R version 
3.3.1 (The R Foundation for Statistical Computing, Vienna, 
Austria).
Methods for the systematic review 
and meta‑analysis
Data sources, searches, extraction, and quality assessment
The systematic review was conducted using a predefined 
protocol and reported in accordance with the PRISMA and 
MOOSE guidelines [28, 29]. Medline (Ovid), Embase.com, 
and the Cochrane Central Register of Controlled Trials 
were searched from inception until August 27, 2019 (date 
last searched), with assistance of an experienced biomedi-
cal information specialist. The detailed search strategy is 
shown in Supplemental Table 2. Two independent review-
ers conducted an initial screening of all titles or abstracts 
and then evaluated all potentially relevant articles based 
on full text reviews. Eligible studies were included if they 
(1) were observational studies with a longitudinal design 
(i.e., prospective cohort); and (2) had assessed the vari-
ance of estimates of the association between dietary protein 
intake (total, animal and/or plant protein) with all-cause 
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mortality and/or cause-specific mortality in a general popu-
lation (i.e., populations that were not selected based on pre-
existing health conditions). We contacted the investigators 
for relevant data if their studies were potentially eligible for 
this study. We extracted the following characteristics from 
the included studies: first author, cohort name, country, 
publication year, age at entry, sex, sample size, duration of 
follow-up, assessment of dietary protein intake, ascertain-
ment of outcomes, the most adjusted association estimates 
and corresponding measures of variation, and variables 
that were entered into the multivariable model as poten-
tial confounders. In case of multiple publications from the 
same study, we included the most up-to date or comprehen-
sive information. We used the nine-star Newcastle–Ottawa 
Scale (NOS) to assess study quality based on selection of 
three domains: selection of participants (population repre-
sentativeness), comparability (adjustment for confounders), 
and ascertainment of outcomes of interest. Nine points on 
the NOS reflects the highest study quality [30].
Data synthesis and analysis
We conducted highest versus lowest and dose–response 
meta-analyses, using the most adjusted association estima-
tion from each original study. For the main meta-analysis, 
we estimated pooled RRs for highest versus lowest quan-
tile of protein intake using random-effects models [31]. 
Heterogeneity was determined using the Cochrane χ2 sta-
tistic and the  I2 statistic [32]. We additionally conducted 
dose–response meta-analyses for all-cause, CVD, and can-
cer mortality, using a generalized least-squares regression 
approach [33]. In estimating dose–response trends, several 
approximations across categories of dietary protein intake 
were applied: the midpoint or mean value of the amount 
of dietary protein intake, distributions of deaths and per-
son years, HR and 95% CI. When sufficient data (n ≥ 5) 
studies [34] contributed to a dose–response meta-analysis, 
non-linearity was explored using restricted cubic splines 
with three knots (10%, 50%, and 90%) [35]. A Wald-type 
test was used to test statistical significance of non-linearity 
[35].
In the main meta-analyses comparing quantiles, we con-
ducted subgroup analyses stratified by geographical study 
location. As sensitivity analysis, we examined the influence 
of individual studies on the overall risk estimates compar-
ing quantiles by recalculating the pooled estimates after 
excluding one study at a time. As a second set of sensitiv-
ity analyses, we additionally incorporated studies report-
ing estimations not expressed in E% in the dose–response 
meta-analysis, for which we could only approximate 
protein intake in E% [14]. Additionally, publication bias 
was evaluated through a funnel plot [36] and Egger’s test 
[37, 38]. We used STATA release 12 (Stata Corp, College 
Station, Texas) for all highest versus lowest meta-analy-
ses. The dose–response meta-analysis was conducted with 
“dosresmeta” package [35] in R version 3.3.1 (The R Foun-
dation for Statistical Computing, Vienna, Austria).
Results
Results in the Rotterdam Study
Characteristics of population
For the 7786 participants of the Rotterdam Study in our 
current analysis, mean age at baseline was 63.7 ± 8.7 years, 
and 60.8% of all participants were female. Further-
more, average total protein intake was 85.8 ± 25.1  g/
day (16.4% ± 2.3% of total energy), this corresponded to 
1.20 ± 0.3 g/kg BW/day, which is higher than the recom-
mended intake of 0.8 g/kg BW/day [39]. Most protein came 
from animal sources (53.6 ± 19.0 g/day, and 10.3% ± 2.5% 
of total energy). Compared to participants in the lowest 
quartile of animal protein intake, those in the highest 
quartile of animal protein had a slightly higher BMI, were 
more often lower educated, and more likely to smoke. In 
contrast, compared to the participants in the lowest quar-
tile of plant protein intake, those in the highest quartile 
of plant protein intake had higher overall diet quality, and 
were more often highly educated, and less likely to smoke 
(Table 1, Supplemental Table 3). 
Associations of protein intake with all‑cause mortality 
and cause‑specific mortality
During a median follow-up of 13.0  years (IQR 
8.3–19.1 years) for all-cause mortality (data available 
until May 2018), we documented 3589 deaths. During 
a median follow-up of 12.9 years (25th–75th percentile, 
8.3–19.0 years) for cause-specific mortality (data available 
until January 2015), we documented 877 CVD deaths (of 
which, 594 non-stroke CVD deaths and 283 stroke deaths), 
896 cancer deaths, and 1289 deaths due to other causes 
(which consisted of various specific causes, all with rela-
tively small numbers).
As shown in Table 2, in multivariable models (Model 
2), higher total protein intake was associated with higher 
risk of all-cause mortality, CVD mortality, and non-stroke 
CVD mortality [e.g. for all-cause mortality, the highest 
quartile versus the lowest quartile of total protein intake 
as percentage of energy (Q4 versus Q1), HR: 1.12, 95%CI 
(1.01, 1.25); per 5 E% increment in total protein, HR: 1.09, 
95%CI (1.02, 1.17); and for CVD mortality, per 5 E% 
HR: 1.20, 95%CI (1.05, 1.37)]. These associations were 
mainly explained by animal protein intake (Table 3) [e.g. 
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Table 1  Characteristics of the Rotterdam Study population (n = 7786)
(n = 7786) By extreme quartiles of total protein By extreme quartiles of animal protein By extreme quartiles of plant 
protein
Quartile 1 
(n = 1947)
≤ 14.4 E%
Quartile 4 
(n = 1947)
> 18.1 E%
Quartile 1 
(n = 1947)
≤8.4 E%
Quartile 4 
(n = 1947)
> 12.1 E%
Quartile 1 
(n = 1947)
≤ 5.2 E%
Quartile 4 
(n = 1947)
> 6.7 E%
Age (years) 63.7 (8.7) 63.9 (9.4) 64.2 (8.2) 62.1 (9.1) 64.9 (8.2)* 66.2 (8.8) 60.6 (7.9)*
Sex (%)
 Female 60.8 12.8 18.4* 12.9 17.9* 13.9 15.6*
 Male 39.2 12.7 6.6* 12.1 7.1* 11.1 9.4*
BMI (kg/m2) 26.6 (3.9) 25.8 (3.6) 27.5 (4.3)* 25.8 (3.7) 27.4 (4.2)* 26.4 (3.7) 26.6 (4.1)
Smoking status (%)
 Never 23.8 7.2 9.3 7.8 8.9 6.8 9.1
 Ever 42.3 11.0 10.1 11.4 9.8 9.6 11.2
 Current 23.8 6.7 5.4* 5.7 6.2* 8.5 4.7*
Education level (%)
 Primary 15.3 3.6 4.1 3.1 4.5 4.6 3.1
 Low 41.1 10.0 10.9 9.5 10.9 10.8 9.6
 Intermediate 27.2 7.2 6.6 7.1 6.4 6.6 6.5
 High 15.8 4.1 3.2 5.2 3.1* 2.9 5.7*
Physical activity (MET-hours/week)
 RS-I and II 80.4 (55.7113.2) 74.3 (47.8, 105.6) 83.9 (59.8, 117.5)* 76.7 (49.5108.7) 83.0 (58.1, 116.0)* 75.9 (47.6, 105.5) 84.8 (61.6, 
121.0)*
 RS-III 43.0 (17.7, 82.6) 41.0 (17.1,84.3) 39.4 (15.0, 56.4) 42.8 (18.0,84.1) 38.0 (15.0, 72.4) 38.0 (16.0, 72.4) 48.0 (18.7, 
87.8)*
Dietary intake
 Total protein (g/
day)
85.8 (25.1) 76.6 (21.2) 90.2 (25.4)* 78.9 (23.4) 90.4 (25.5)* 83.5 (25.0) 86.2 (24.3)*
 Total protein 
(E%)
16.4 (2.3) 13.0 (1.3) 20.3 (2.1)* 13.4 (1.7) 20.0 (2.3)* 15.8 (3.2) 16.8 (2.9)*
  Animal 
protein(g/
day)
53.6 (19.0) 42.9 (14.0) 63.0 (30.0)* 40.5 (13.3) 65.5 (20.9)* 59.4 (21.6) 46.2 (15.8)*
  Animal protein 
(E%)
10.3 (2.5) 7.3 (1.6) 14.2 (2.5)* 6.9 (1.3) 14.5 (2.2)* 11.3 (3.3) 9.1 (3.0)*
  Protein from 
meat (g/day)
21.8 (11.7) 18.2 (9.5) 25.0 (14.6)* 16.7 (9.4) 26.0 (14.7)* 24.4 (13.9) 18.5 (10.5)*
  Protein from 
meat (E%)
4.3 (2.1) 3.1 (1.4) 5.6 (2.6)* 2.8 (1.3) 5.8 (2.6)* 4.7 (2.4) 3.7 (2.0)*
  Protein from 
dairy (g/day)
22.0 (12.3) 17.5 (9.3) 26.6 (14.6)* 16.6 (8.8) 27.9 (15.3)* 24.9 (15.2) 19.0 (10.3)*
  Protein from 
dairy (E%)
4.3 (2.3) 3.0 (1.4) 6.0 (2.8)* 2.8 (1.3) 6.1 (2.8)* 4.7 (2.5) 3.8 (2.1)*
  Protein from 
fish (g/day)
4.0 (4.7) 3.2 (3.8) 4.7 (5.7)* 3.5 (3.8) 4.6 (5.7)* 3.9 (4.8) 4.2 (4.5)
  Protein from 
fish (E%)
0.8 (0.9) 0.5 (0.6) 1.1 (1.2) 0.6 (0.6) 1.0 (1.2)* 0.7 (1.0) 0.8 (0.9)
  Protein from 
eggs (g/day)
1.9 (1.5) 1.8 (1.4) 1.8 (1.4) 1.7 (1.5) 1.9 (1.5) 2.1 (1.6) 1.7 (1.4)
  Protein from 
eggs (E%)
0.4 (0.3) 0.3 (0.2) 0.4 (0.3) 0.3 (0.3) 0.4 (0.3) 0.4 (0.3) 0.3 (0.3)
  Plant protein 
(g/day)
30.3 (8.9) 33.7 (12.1) 27.2 (9.4)* 38.4 (13.7) 25.0 (7.6)* 24.0 (7.1) 39.9 (13.5)*
  Plant protein 
(E%)
6.2 (1.5) 5.7 (1.3) 6.1 (1.5)* 6.5 (1.6) 5.6 (1.2)* 4.5 (0.6) 7.6 (1.1)*
  Protein from 
grains (g/
day)
16.0 (7.6) 17.1 (8.1) 13.8 (6.3)* 20.0 (9.3) 12.6 (5.5)* 11.9 (5.1) 20.5 (9.4)*
  Protein from 
grains (E%)
3.1 (1.12) 2.9 (1.1) 3.1 (1.2) 3.3 (1.2) 2.8 (1.1)* 2.2 (0.8) 3.9 (1.2)*
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Q4 versus Q1, for all-cause mortality, 1.18 (1.05, 1.31), 
for CVD mortality, 1.28 (1.03, 1.60); per 5 E% increment, 
for all-cause mortality, 1.20 (1.05, 1.37); for CVD mor-
tality, 1.19 (1.04, 1.37)]. Total, or animal protein intake 
was not associated with stroke mortality, cancer mortality, 
and other mortality. Plant protein intake was not associated 
with all-cause and cause-specific mortality (Table 4).
We further examined associations of protein intake from 
more specific animal and plant food sources with mortality. 
As shown in Table 5, higher intake of protein from meat 
and dairy was associated with higher all-cause mortality, 
CVD mortality, non-stroke CVD mortality, and other mor-
tality [e.g. for CVD mortality, per 5 E% protein from meat: 
1.32 (1.12, 1.57), protein from dairy: 1.27 (1.09, 1.49)], 
although not with stroke mortality and cancer mortality. 
Protein intake from fish and eggs was not associated with 
all-cause and cause-specific mortality. For protein intake 
from more specific plant food sources, higher intake of pro-
tein from grains and potatoes was not associated with all-
cause and cause-specific mortality [e.g. for CVD mortality, 
per 3 E% protein from grains: 1.11 (0.87, 1.40)], but higher 
intake of protein from legumes, nuts, vegetables, and fruits 
Table 1  (continued)
(n = 7786) By extreme quartiles of total protein By extreme quartiles of animal protein By extreme quartiles of plant 
protein
Quartile 1 
(n = 1947)
≤ 14.4 E%
Quartile 4 
(n = 1947)
> 18.1 E%
Quartile 1 
(n = 1947)
≤8.4 E%
Quartile 4 
(n = 1947)
> 12.1 E%
Quartile 1 
(n = 1947)
≤ 5.2 E%
Quartile 4 
(n = 1947)
> 6.7 E%
  Protein from 
potatoes (g/
day)
2.3 (1.4) 2.5 (1.5) 2.0 (1.3)* 2.3 (1.5) 2.0 (1.2)* 2.3 (1.3) 2.1 (1.5)
  Protein from 
potatoes 
(E%)
0.4 (0.3) 0.4 (0.3) 0.5(0.3) 0.4 (0.3) 0.5 (0.3) 0.4 (0.2) 0.4 (0.3)
  Protein from 
legumes, 
nuts, veg-
etables, and 
fruits (g/day)
10.1 (8.7) 10.7 (9.3) 8.9 (7.9)* 14.0 (11.3) 7.6 (6.5)* 6.2 (5.0) 16.0 (11.5)*
  Protein from 
legumes, 
nuts, veg-
etables, and 
fruits (E%)
1.90 (1.5) 1.8 (1.4) 2.0 (1.7)* 2.4 (1.8) 1.7 (1.4)* 1.2 (1.0) 3.0 (1.9)*
 Total fat (g/day) 82.7 (29.7) 93.5 (34.2) 68.9 (24.2)* 72.8 (27.0) 90.9 (35.1)* 91.2 (33.3) 76.5 (29.7)*
 Total fat (E%) 35.3 (6.6) 35.3 (7.3) 34.5 (6.2)* 34.3 (7.3) 35.6 (6.5)* 38.1 (7.1) 32.3 (6.0)*
  SFA (g/day) 31.7 (12.3) 35.1 (13.6) 27.0 (10.7)* 29. 2 (12.5) 32.8 (13.4)* 37.1 (14.4) 26.8 (10.5)*
  SFA (E%) 13.6 (3.3) 13.3 (3.4) 13.5 (3.3)* 12.4 (3.3) 14.2 (3.4)* 15.5 (3.5) 11.5 (2.6)*
  MUFA (g/day) 27.8 (11.2) 31.8 (13.2) 23.0 (8.6)* 24.3 (13.7) 30.9 (9.4)* 30.9 (12.7) 25.9 (11.2)*
  MUFA (E%) 11.8 (2.8) 11.9 (3.2) 11.5 (2.5)* 11.5 (3.2) 11.9 (2.7)* 12.8 (3.2) 11.0 (2.7)*
  PUFA (g/day) 16.5 (7.8) 19.3 (9.3) 13.0 (6.0)* 19.8 (9.4) 13.1 (6.2)* 16.4 (8.5) 17.0 (8.1)*
  PUFA (E%) 7.0 (2.5) 7.2 (2.7) 6.5 (2.5)* 7.4 (2.7) 6.5 (2.5)* 6.8 (2.7) 7.2 (2.3)*
  TSF (g/day) 1.7 (1.2, 2.4) 1.9 (1.3, 2.9) 1.4 (1.0, 1.9) 1.6 (1.1, 2.4) 1.5 (1.1, 2.1)* 2.1 (0.25, 3.21) 1.27 (0.91, 
1.80)*
  TSF (E%) 0.72 (0.52, 1.05) 0.72 (0.52, 1.10) 0.72 (0.54, 0.97) 0.61 (0.45, 0.92) 0.77 (0.59, 1.06)* 0.92 (0.65, 1.33) 0.56 (0.43, 
0.74)*
Carbohydrate (g/
day)
228.2 (76.6) 269.0 (86.5) 186.2 (56.2)* 275.0 (87.1) 183.9 (56.3)* 216.4 (77.7) 243.7 (80.9)*
Carbohydrate (E%) 43.5 (7.1) 45.5 (7.9) 41.9 (6.7)* 46.7 (7.6) 40.6 (6.8)* 40.1 (7.9) 46.6 (6.4)*
Diet quality score 6.7 (1.9) 6.3 (2.0) 7.2 (1.8)* 6. 8 (2.0) 6.9 (1.8) 5.7 (1.7) 7.7 (1.7)*
Fiber (g) 19.5 (15.1, 26.6) 20.8 (15.4, 28.9) 17.7(14.3, 22.6)* 24.6 (18.1, 33.9) 16.6 (13.6, 20.9)* 15.2 (12.2, 19.5) 26.2 (19.6, 
35.2)*
Variables expressed as mean (SD), median (25th percentile–75th percentile), or percentage
MET metabolic equivalent of task, E% energy percent, SFA saturated fat acids, MUFA monounsaturated fat acids, PUFA polyunsaturated fat 
acids, TSF trans fat acid
P-trend was assessed were tested with linear regression (continuous variables) or with Chi square test (categorical variables). *P < 0.05 for trend 
across quartiles
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was associated with lower risk of all-cause, CVD, non-
stroke CVD, stroke, cancer, and other mortality [e.g. for 
CVD mortality, per 3 E% protein from legumes, nuts, veg-
etables, and fruits, 0.75 (0.58, 0.97)].
Sensitivity analyses
In the Rotterdam Study, we observed similar results for 
protein intake and all-cause and cause-specific mortal-
ity when at the expense of fat instead of carbohydrate 
(Supplemental Table 4). We also observed no interaction 
effects of protein intake with age, BMI, or physical activ-
ity, but we did observe a significant interaction effect of 
animal protein intake with sex for all-cause mortality 
(P value for the interaction term = 0.02). Specifically, 
the association between animal protein intake and all-
cause mortality was significant in male participants [Q4 
versus Q1: 1.42 (1.20, 1.68), per 5 E% increment: 1.42 
(1.13, 1.77)]; while the association was null in female 
participants [Q4 versus Q1: 1.01 (0.87, 1.17), per 5 E% 
increment: 1.04 (0.90, 1.21)]. There was no interaction 
between protein intake and sex for cause-specific mortal-
ity. The results were similar with the adjustment for the 
modified diet quality score without main protein food 
sources (data not shown). Last, the results were similar 
after excluding deaths cases within the first 2 years of 
follow-up (Supplemental Table 5).
Table 2  Associations of total protein intake with all-cause and cause-specific mortality in the Rotterdam Study (n = 7786, comparison is isoca-
loric substitution for carbohydrate)
Effect estimates are hazard ratios (HRs) and 95%-confidence intervals (95%CIs) derived from Cox proportional hazards regression models. Esti-
mates are based on pooled results of imputed data
Model 1: age, sex, RS-cohort (RS-I, -II, and -III), intake of total energy, SFA (E%), MUFA (E%), PUFA (E%), TSFA (E%), and alcohol (E%)
Model 2: Model 1 + fiber, overall diet quality score, physical activity (z-score of metabolic equivalents of task-hours/week), education level (pri-
mary, lower, intermediate, and high), smoking status (never, ever, current), and BMI
SFA saturated fat acids, MUFA monounsaturated fat acids, PUFA polyunsaturated fat acids, TSF trans fat acids, BMI body mass index
Total protein HR (95% CI) per 5 
E% increment
Quartile 1 Quartile 2 Quartile 3 Quartile 4 P trend
n = 7786 n = 1947 n = 1946 n = 1946 n = 1947
Median intake (E%) 16.2 13.3 15.3 17.0 19.7
All-cause mortality
 Number of deaths n = 3589 n = 878 n = 853 n = 884 n = 974
 Model 1 1.04 (0.97, 1.11) 1 (Reference) 1.00 (0.91, 1.10) 0.96 (0.87, 1.05) 1.04 (0.93, 1.15) 0.60
 Model 2 1.09 (1.02, 1.17) 1 (Reference) 1.05 (0.95, 1.16) 1.02 (0.92, 1.13) 1.12 (1.01, 1.25) 0.06
Cardiovascular mortality
 Number of deaths n = 877 n = 220 n = 191 n = 205 n = 261
 Model 1 1.16 (1.01, 1.32) 1 (Reference) 0.95 (0.78, 1.16) 0.93 (0.76, 1.14) 1.16 (0.94, 1.42) 0.15
 Model 2 1.20 (1.05, 1.37) 1 (Reference) 0.99 (0.81, 1.21) 0.99 (0.80, 1.21) 1.22 (0.99, 1.52) 0.06
Non-stroke CVD mortality
 Number of deaths n = 594 n = 147 n = 125 n = 143 n = 179
 Model 1 1.24 (1.06, 1.45) 1 (Reference) 0.93 (0.73, 1.18) 0.96 (0.76, 1.23) 1.19 (0.92, 1.53) 0.13
 Model 2 1.27 (1.08, 1.49) 1 (Reference) 0.96 (0.75, 1.23) 1.02 (0.79, 1.31) 1.23 (0.95, 1.60) 0.04
Stroke mortality
 Number of deaths n = 283 n = 73 n = 66 n = 62 n = 82
 Model 1 0.99 (0.78, 1.24) 1 (Reference) 1.00 (0.71, 1.40) 0.85 (0.59, 1.21) 1.09 (0.76, 1.57) 0.86
 Model 2 1.05 (0.83, 1.33) 1 (Reference) 1.04 (0.74, 1.47) 0.91 (0.64, 1.32) 1.19 (0.82, 1.74) 0.42
Cancer mortality
 Number of deaths n = 896 n = 243 n = 220 n = 220 n = 213
 Model 1 0.92 (0.81, 1.06) 1 (Reference) 0.92 (0.76, 1.10) 0.87 (0.71, 1.05) 0.84 (0.68, 1.04) 0.10
 Model 2 0.94 (0.82, 1.08) 1 (Reference) 0.95 (0.78, 1.14) 0.89 (0.73, 1.08) 0.87 (0.70, 1.08) 0.18
Other mortality
 Number of deaths n = 1289 n = 311 n = 309 n = 318 n = 351
 Model 1 1.00 (0.90, 1.11) 1 (Reference) 1.04 (0.89, 1.22) 0.95 (0.80, 1.12) 1.02 (0.86, 1.22) 0.99
 Model 2 1.09 (0.97, 1.22) 1 (Reference) 1.12 (0.95, 1.32) 1.06 (0.89, 1.25) 1.16 (0.97, 1.39) 0.17
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Meta‑analysis results of the Rotterdam Study 
and previous prospective cohort studies
Literature search and characteristics of studies
In the initial search, we identified 12,152 potentially rel-
evant unique citations. After screening and detailed full-
text assessment, ten previously published articles were 
eligible for the systematic review [7–14, 16, 40]. Finally, 
ten previous studies were eligible for the meta-analysis 
[7–14, 16, 40], resulting in a total of eleven prospective 
studies including the Rotterdam study, with a total number 
of 350,452 participants and 64,306 deaths (Supplemental 
Figure 2). Furthermore, the number of participants (from 
1100 to 131,342) and deaths (from 60 to 36,115) varied 
widely across these eleven studies. Median duration of fol-
low-up ranged from 12.0 to 28.0 years. Among the eleven 
studies, most study populations were middle-aged at 
baseline (Table 6). Moreover, of the eleven studies, eight 
[8–11, 13, 14, 40] were conducted among North American 
and European populations (87% of total participants of 
this meta-analysis), in which the mean or median intake 
of total protein ranged from around 70 through 93 g/day, 
mainly from animal protein intake with a mean or median 
ranging from around 54 through 65 g/day. Three studies 
were conducted within Japanese populations, with a total 
Table 3  Associations of animal protein with all-cause and cause-specific mortality in the Rotterdam Study (n = 7786, comparison is isocaloric 
substitution for carbohydrate)
Effect estimates are hazard ratios (HRs) and 95%-confidence intervals (95%CIs) derived from Cox proportional hazards regression models. Esti-
mates are based on pooled results of imputed data
Model 1: age, sex, and RS-cohort (RS-I, -II, and –III), total energy, plant protein (E%), SFA (E%), MUFA (E%), PUFA (E%), TSFA (E%), and 
alcohol (E%)
Model 2: Model 1 + fiber, overall diet quality score, physical activity (z-score of metabolic equivalents of task-hours/week), education level (pri-
mary, lower, intermediate, and high), smoking status (never, ever, current), and BMI
SFA saturated fat acids, MUFA monounsaturated fat acids, PUFA polyunsaturated fat acids, TSF trans fat acids, BMI body mass index
Animal protein HR (95% CI) per 5 
E% increment
Quartile 1 Quartile 2 Quartile 3 Quartile 4 P trend
n = 7786 n = 1947 n = 1946 n = 1946 n = 1947
Median intake (E%) 10.2 7.2 9.3 11.1 13.9
All-cause mortality
 Number of deaths n = 3589 n = 692 n = 887 n = 970 n = 1040
 Model 1 1.10 (0.96, 1.25) 1 (Reference) 1.07 (0.96, 1.18) 1.05 (0.95, 1.16) 1.13 (1.01, 1.26) 0.04
 Model 2 1.20 (1.05, 1.37) 1 (Reference) 1.06 (0.95, 1.17) 1.08 (0.97, 1.20) 1.18 (1.05, 1.31) 0.003
Cardiovascular mortality
 Number of deaths n = 877 n = 169 n = 216 n = 219 n = 273
 Model 1 1.16 (1.02, 1.32) 1 (Reference) 1.08 (0.88, 1.32) 0.97 (0.79, 1.20) 1.24 (1.00, 1.54) 0.08
 Model 2 1.19 (1.04, 1.37) 1 (Reference) 1.07 (0.87, 1.32) 1.01 (0.82, 1.25) 1.28 (1.03, 1.60) 0.03
Non-stroke CVD mortality
 Number of deaths n = 594 n = 109 n = 145 n = 150 n = 190
 Model 1 1.25 (1.07, 1.47) 1 (Reference) 1.11 (0.86, 1.43) 1.05 (0.81, 1.35) 1.36 (1.04, 1.77) 0.02
 Model 2 1.27 (1.08, 1.49) 1 (Reference) 1.10 (0.85, 1.42) 1.06 (0.81, 1.37) 1.34 (1.03, 1.75) 0.03
Stroke mortality
 Number of deaths n = 283 n = 60 n = 71 n = 69 n = 83
 Model 1 0.98 (0.78, 1.24) 1 (Reference) 1.01 (0.71, 1.43) 0.84 (0.58, 1.21) 1.03 (0.71, 1.49) 0.99
 Model 2 1.05 (0.83, 1.33) 1 (Reference) 1.01 (0.71, 1.44) 0.90 (0.62, 1.30) 1.12 (0.76, 1.64) 0.64
Cancer mortality
 Number of deaths n = 896 n = 184 n = 248 n = 230 n = 234
 Model 1 0.93 (0.82, 1.07) 1 (Reference) 1.09 (0.90, 1.32) 0.94 (0.77, 1.15) 0.97 (0.78, 1.21) 0.51
 Model 2 0.95 (0.82, 1.08) 1 (Reference) 1.08 (0.89, 1.32) 0.94 (0.77, 1.16) 0.98 (0.78, 1.22) 0.54
Other mortality
 Number of deaths n = 1289 n = 240 n = 301 n = 364 n = 384
 Model 1 1.02 (0.92, 1.14) 1 (Reference) 1.02 (0.86, 1.21) 1.03 (0.87, 1.22) 1.09 (0.91,1.31) 0.22
 Model 2 1.09 (0.97, 1.22) 1 (Reference) 1.03 (0.86, 1.22) 1.11 (0.93, 1.32) 1.21 (1.00, 1.46) 0.07
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of 82,171 participants [7, 12, 16]. Detailed characteristics 
and quality assessment of these studies have been summa-
rized in Table 6 and Supplemental Table 6. Overall, all the 
eleven studies were medium to high quality.
Meta‑analyzed associations for protein intake 
and all‑cause and cause‑specific mortality
Highest versus lowest meta‑analysis
Nine studies [7–13, 16] including the Rotterdam Study 
presented associations of comparing the highest with 
the lowest categories of protein intake with mortality, 
and thus were summarized into the highest versus lowest 
meta-analysis. Figure 1 shows the results of the highest 
versus lowest meta-analysis. Of the nine studies, six exam-
ined associations [8, 10, 11, 13, 16] for total protein intake 
with all-cause mortality (59,841 all-cause deaths among 
247,863 participants). Comparing the highest quantile of 
total protein intake with the lowest quantile, the pooled RR 
was 1.05, 95%CI (1.01, 1.10),  I2 = 9.8%, Pheterogeneity = 0.35 
for all-cause mortality. Five studies [8, 10, 11, 16] exam-
ined associations for total protein and CVD mortality 
(14,704 CVD deaths among 245,222 participants), with 
a pooled estimate of 1.08, 95%CI (0.98, 1.20),  I2 = 20.4%, 
Pheterogeneity = 0.29. Six studies [8–11, 16] examined asso-
ciations for total protein and cancer mortality; and two 
Table 4  Associations of plant protein with all-cause and cause-specific mortality in the Rotterdam study (n = 7786, comparison is isocaloric sub-
stitution for carbohydrate)
Effect estimates are hazard ratios (HRs) and 95%-confidence intervals (95%CIs) derived from Cox proportional hazards regression models. Esti-
mates are based on pooled results of imputed data
Model 1: age, sex, and RS-cohort (RS-I, -II, and -III), total energy, animal protein (E%), SFA (E%), MUFA (E%), PUFA (E%), TSFA (E%), and 
alcohol (E%)
Model 2: Model 1 + fiber, overall diet quality score, physical activity (z-score of metabolic equivalents of task-hours/week), education level (pri-
mary, lower, intermediate, and high), smoking status (never, ever, current), and BMI
SFA saturated fat acids, MUFA monounsaturated fat acids, PUFA polyunsaturated fat acids, TSF trans fat acids, BMI body mass index
Plant protein HR (95% CI) per 5 
E% increment
Quartile 1 Quartile 2 Quartile 3 Quartile 4 P trend
n = 7786 n = 1947 n = 1946 n = 1946 n = 1947
Median intake (% energy) 5.8 4.6 5.5 6.2 7.3
All-cause mortality
 Number of deaths n = 3589 n = 1176 n = 986 n = 813 n = 614
 Model 1 0.80 (0.67, 0.95) 1 (Reference) 0.85 (0.78, 0.93) 0.84 (0.76, 0.93) 0.90 (0.80, 1.01) 0.05
 Model 2 1.09 (0.88, 1.35) 1 (Reference) 0.93 (0.85, 1.03) 0.94 (0.84, 1.04) 1.06 (0.92, 1.21) 0.53
Cardiovascular mortality
 Number of deaths n = 877 n = 282 n = 235 n = 210 n = 150
 Model 1 1.02 (0.72, 1.46) 1 (Reference) 0.88 (0.74, 1.06) 0.98 (0.80, 1.19) 1.03 (0.81, 1.30) 0.72
 Model 2 1.28 (0.84,1.96) 1 (Reference) 0.96 (0.80, 1.17) 1.06 (0.86, 1.31) 1.19 (0.91, 1.57) 0.17
Non-stroke CVD mortality
 Number of deaths n = 594 n = 190 n = 155 n = 148 n = 101
 Model 1 1.03 (0.67, 1.59) 1 (Reference) 0.85 (0.68, 1.05) 0.99 (0.78, 1,25) 0.98 (0.74, 1.31) 0.91
 Model 2 1.32 (0.79, 2.22) 1 (Reference) 0.92 (0.73, 1.17) 1.07 (0.83, 1.39) 1.16 (0.83, 1.62) 0.29
Stroke mortality
 Number of deaths n = 283 n = 92 n = 80 n = 62 n = 49
 Model 1 1.09 (0.55, 2.16) 1 (Reference) 0.96 (0.70, 1.31) 0.96 (0.68, 1.37) 1.13 (0.74,1.71) 0.64
 Model 2 1.36 (0.61, 3.03) 1 (Reference) 1.05 (0.76, 1.46) 1.05 (0.72, 1.52) 1.27 (0.79, 2.04) 0.37
Cancer mortality
 Number of deaths n = 896 n = 305 n = 227 n = 204 n = 160
 Model 1 0.72 (0.48, 1.04) 1 (Reference) 0.76 (0.64, 0.91) 0.80 (0.66, 0.97) 0.82 (0.65, 1.03) 0.08
 Model 2 0.84 (0.53, 1.32) 1 (Reference) 0.81 (0.68, 0.98) 0.85 (0.69, 1.04) 0.90 (0.69, 1.17) 0.44
Other mortality
 Number of deaths n = 1289 n = 441 n = 392 n = 261 n = 195
 Model 1 0.59 (0.43, 0.83) 1 (Reference) 0.92 (0.80, 1.07) 0.75 (0.64, 0.89) 0.85 (0.69, 1.03) 0.01
 Model 2 0.90 (0.62, 1.3) 1 (Reference) 1.04 (0.89, 1.21) 0.87 (0.73, 1.04) 1.06 (0.84, 1.34) 0.87
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studies [11] on other mortality. For both these outcomes, 
pooled RRs were null (Fig. 1a).
For animal protein intake, five studies reported associa-
tions with all-cause mortality [8, 11, 13, 16], CVD mor-
tality [7, 8, 11, 16], or cancer mortality [8, 9, 11, 16], and 
two studies [11] with other mortality (Fig. 1b). While null 
pooled associations were observed for all-cause, cancer, 
and other mortality, a significant pooled RR was observed 
for CVD mortality: 1.09, 95%CI (1.01, 1.18),  I2 = 0.0%, 
Pheterogeneity = 0.43. For plant protein intake, similar stud-
ies were included with a pooled RR of 0.93, 95%CI (0.87, 
0.99),  I2 = 38.7%, Pheterogeneity = 0.16 for all-cause mortal-
ity, and 0.86 (0.73, 1.00),  I2 = 48.2%, Pheterogeneity = 0.09 for 
CVD mortality. We observed null associations for plant 
protein and cancer mortality and other mortality (Fig. 1c).
Dose–response meta‑analysis
We performed dose–response meta-analysis based on six 
studies [10–13, 16] (Supplemental Table 7), from which 
sufficient data could be extracted to estimate dose–response 
estimates. In these studies, the median animal protein 
intake ranged from 4.3 E% through 20.0 E%, and plant pro-
tein from 2.6 E% through 8.4 E%. We found no evidence 
for non-linear associations (Wald test: P > 0.05). In line 
with the highest versus lowest meta-analysis, we observed 
a positive linear association between total protein intake 
and all-cause mortality (per 5 E% increment, 1.02 (1.004, 
1.04),  I2 = 37.9%, Pheterogeneity = 0.17), mainly driven by ani-
mal protein intake and CVD mortality [Per 5 E% increment, 
1.05 (1.02, 1.09),  I2 = 31.2%, Pheterogeneity = 0.23)] (Supple-
mental Table 7, Fig. 2a, b). Furthermore, we observed an 
inverse linear association between plant protein intake with 
all-cause mortality (per 5 E% increment, 0.87 (0.78, 0.98), 
 I2 = 40.0%, Pheterogeneity = 0.17) (Supplemental Table  7, 
Fig. 2c). We observed no dose–response associations for 
the other examined associations (Supplemental Table 7).
Subgroup and sensitivity meta‑analysis
We observed that several meta-analysis results were 
modified by geographical study location (Supplemental 
Table 8). For total protein and all-cause mortality and for 
animal protein and CVD mortality, positive associations 
were observed in North American and European popula-
tions, whereas null associations were observed in Japa-
nese populations. For plant protein, inverse associations 
with all-cause and CVD mortality were only observed 
in North American and Japanese populations, but not in 
European populations (Supplemental Table 8). For the 
sensitivity analyses, as shown in Supplemental Table 9, 
the pooled associations were similar after excluding 
one study at each turn; and thus, were not driven by 
one individual study. Supplemental Table 10 shows the 
results of the second set of sensitivity analysis in which 
we included two additional studies in the dose–response 
meta-analysis that did not report associations for pro-
tein in E% but rather in g/day [14] or in SD [40]. After 
incorporating results from the study by Bates et al. [40] 
for total protein intake with all-cause mortality and CVD 
Table 5  Associations of protein intake from various foods with all-cause and cause-specific mortality in the Rotterdam Study (n = 7786, com-
parison isocaloric substitution for carbohydrate)
Effect estimates are hazard ratios (HRs) and 95%-confidence intervals (95%CIs) derived from Cox proportional hazards regression models with 
adjustment for SFA (E%), MUFA (E%), PUFA (E%), TSF (E%), total energy, alcohol (E%), fiber, age, sex, RS-cohorts (RS-I, -II, and -III), edu-
cation level(primary, lower, intermediate, and high), smoking status (never, ever, current), physical activity (z-score of metabolic equivalents of 
task-hours/week), diet quality score, and BMI. Protein from meat, fish, dairy, and eggs and protein from grains, potatoes, and legumes, nuts and 
vegetables are mutually adjusted. Estimates are based on pooled results of imputed data
SFA saturated fat acids, MUFA monounsaturated fat acids, PUFA polyunsaturated fat acids, TSF trans fat acids, BMI body mass index
All-cause mortality CVD mortality Non-stroke CVD 
mortality
Stroke mortality Cancer mortality Other mortality
HR (95%CI) HR (95%CI) HR (95%CI) HR (95%CI) HR (95%CI) HR (95%CI)
Protein intake (per 5 E%)
 From meat 1.16 (1.07, 1.27) 1.32 (1.12, 1.57) 1.35 (1.10, 1.66) 1.27 (0.94, 1.71) 1.03 (0.87, 1.22) 1.23 (1.07, 1.42)
 From dairy 1.19 (1.10, 1.28) 1.27 (1.09, 1.49) 1.35 (1.12, 1.64) 1.12 (0.85, 1.48) 1.15 (0.98, 1.34) 1.18 (1.04, 1.34)
 From fish 0.83 (0.66, 1.05) 0.99 (0.62, 1.58) 1.22 (0.70, 2.11) 0.60 (0.25, 1.46) 0.88 (0.56, 1.38) 0.75 (0.50, 1.12)
 From eggs 0.78 (0.41, 1.47) 1.49 (0.41, 5.32) 2.01 (0.44, 9.22) 0.75 (0.08, 7.52) 0.50 (0.14, 1.82) 0.57 (0.19, 1.70)
Protein intake (per 3 E%)
 From grains 1.04 (0.94, 1.16) 1.11 (0.87, 1.40) 1.13 (0.85, 1.50) 1.08 (0.71, 1.63) 0.92 (0.74, 1.15) 1.11 (0.91, 1.34)
 From potatoes 0.86 (0.58, 1.27) 1.01 (0.997, 1.01) 2.26 (0.95, 5.37) 1.00 (0.98, 1.01) 1.00 (0.99, 1.01) 1.00 (0.99, 1.00)
 From legumes, nuts, 
vegetables, and 
fruits
0.75 (0.67, 0.85) 0.75 (0.58, 0.97) 0.70 (0.50, 0.96) 0.86 (0.56, 1.31) 0.72 (0.57, 0.92) 0.64 (0.50, 0.80)
 Z. Chen et al.
1 3
Ta
bl
e 
6 
 C
ha
ra
cte
ris
tic
s o
f t
he
 pr
os
pe
cti
ve
 st
ud
ies
 in
clu
de
d i
n t
he
 sy
ste
m
ati
c r
ev
iew
 an
d m
eta
-a
na
lys
is
Le
ve
l o
f a
dj
us
tm
en
t: 
+,
 m
in
im
all
y 
ad
ju
ste
d 
(ty
pi
ca
lly
 ad
ju
ste
d 
fo
r a
ge
, s
ex
, C
VD
 co
nf
ou
nd
er
s i
nc
lu
di
ng
 B
M
J b
ut
 n
ot
 fo
r o
th
er
 n
ut
rit
io
na
l f
ac
to
rs)
; +
+,
 ad
ju
ste
d 
fo
r o
th
er
 m
ac
ro
nu
tri
en
ts 
an
d/
or
 
ot
he
r n
ut
rit
io
na
l f
ac
to
rs;
 +
++
, a
dj
us
ted
 fo
r s
ub
ty
pe
s o
f p
ro
tei
n (
e.g
. a
ni
m
al 
an
d p
lan
t p
ro
tei
n i
nt
ak
e)
. A
ll 
th
e s
tu
di
es
 ad
ju
ste
d f
or
 B
M
I
C
VD
 d
ea
th
 ca
rd
io
va
sc
ul
ar
 di
se
as
es
 de
ath
, N
ew
ca
stl
e–
O
tta
wa
 S
ca
le
 sc
or
e w
ith
 a 
th
eo
re
tic
al 
ra
ng
e f
ro
m
 ze
ro
 to
 ni
ne
 w
ith
 hi
gh
er
 sc
or
es
 re
fle
cti
ng
 hi
gh
er
 st
ud
y d
es
ig
n q
ua
lit
y
1  In
clu
sio
n o
nl
y i
n t
he
 sy
ste
m
ati
c r
ev
iew
 (a
nd
 in
 se
ns
iti
vi
ty
 m
eta
-a
na
lys
is 
of
 do
se
–r
es
po
ns
e)
, n
ot
 in
 th
e m
ain
 m
eta
-a
na
lys
is 
be
ca
us
e o
f d
iff
er
en
t f
or
m
at 
of
 es
tim
ate
s. 
Th
e t
wo
 st
ud
ies
 on
ly
 re
po
rte
d 
es
tim
ate
s o
f c
on
tin
uo
us
 va
ria
bl
e o
f p
ro
tei
n i
nt
ak
e w
ith
 th
e o
ut
co
m
es
, d
id
 no
t r
ep
or
t e
sti
m
ate
s o
f h
ig
he
st 
ve
rsu
s l
ow
es
t c
ate
go
ry
 of
 pr
ot
ein
 in
tak
e
2  N
OS
 sc
or
e, 
Ne
wc
as
tle
–O
tta
wa
 S
ca
le 
sc
or
e w
ith
 a 
th
eo
re
tic
al 
ra
ng
e f
ro
m
 ze
ro
 to
 ni
ne
 w
ith
 hi
gh
er
 sc
or
es
 re
fle
cti
ng
 hi
gh
er
 st
ud
y d
es
ig
n q
ua
lit
y
Au
th
or
, p
ub
lic
ati
on
 
ye
ar
St
ud
y c
oh
or
t/p
op
ul
a-
tio
ns
Co
un
try
Ba
se
lin
e a
ge
 (y
ea
rs,
 
m
ea
n o
r r
an
ge
)
Fe
m
ale
 (%
)
Fo
llo
w-
up
 (y
ea
rs)
Nu
m
be
r o
f 
pa
rti
cip
an
ts
Nu
m
be
r o
f d
ea
th
s
Le
ve
l o
f 
ad
ju
stm
en
t
NO
S2
 sc
or
e
Al
l d
ea
th
s
CV
D 
de
ath
s
Ca
nc
er
 de
ath
s
Sa
uv
ag
et 
et 
al.
 [7
]
Th
e A
du
lt 
He
alt
h 
St
ud
y (
AH
S)
Ja
pa
n
57
10
0
14
37
31
NA
60
NA
++
7
Ke
lem
en
 et
 al
. [
8]
Th
e I
ow
a W
om
en
’s 
He
alt
h S
tu
dy
,
US
55
–6
9
10
0
16
.4
29
,01
7
39
78
73
9
16
76
++
+
8
Sm
it 
et 
al.
 [9
]
Th
e P
ue
rto
 R
ico
 H
ea
rt 
He
alt
h P
ro
gr
am
 
(P
RH
HP
)
Pu
er
to
 R
ico
45
–6
4
0
12
97
77
NA
NA
16
7
++
8
Ba
tes
 et
 al
.1  
[4
0]
Th
e c
om
m
un
ity
-li
vi
ng
 
po
pu
lat
io
n o
f m
ain
-
lan
d B
rit
ain
UK
76
.7
50
.2
14
11
00
74
9
19
9
Na
+
6
Le
vi
ne
 et
 al
. [
10
]
NH
AN
ES
 II
I
US
64
.8
55
.4
13
.1
63
81
25
53
12
12
63
8
++
+
8
So
ng
 et
 al
. [
11
]
Nu
rse
s’ 
He
alt
h S
tu
dy
 
an
d H
ea
lth
 P
ro
fes
-
sio
na
l F
ol
lo
w-
up
 
stu
dy
US
49
64
.7
27
.0
13
1,3
42
36
,11
5
88
51
13
,15
9
++
+
9
Th
ar
rey
 et
 al
.1  
[1
4]
Th
e A
dv
en
tis
t H
ea
lth
 
St
ud
y 2
 (A
HS
-2
)
US
 an
d C
an
ad
a
> 
25
NA
9.4
81
,33
7
NA
22
76
NA
++
+
9
Ku
rih
ar
a e
t a
l. 
[1
2]
Th
e N
ati
on
al 
In
teg
ra
ted
 P
ro
jec
t 
fo
r P
ro
sp
ec
tiv
e 
Ob
se
rv
ati
on
 of
 
No
n-
co
m
m
un
ica
bl
e 
Di
se
as
e a
nd
 It
s 
Tr
en
ds
 in
 th
e A
ge
 
19
90
 (N
IP
PO
N-
DA
TA
90
)
Ja
pa
n
52
.6
58
.4
13
.9
77
44
12
13
35
4
NA
++
+
9
Vi
rta
ne
n e
t a
l. 
[1
3]
Th
e K
uo
pi
o I
sc
ha
em
ic 
He
ar
t D
ise
as
e 
Ri
sk
 F
ac
to
r S
tu
dy
 
(K
IH
D)
Fi
nl
an
d
52
.7–
53
.7
0
22
.31
26
41
12
25
61
8
34
7
++
+
9
Bu
dh
ath
ok
i e
t a
l. 
[1
6]
Ja
pa
n P
ub
lic
 H
ea
lth
 
Ce
nt
er
–b
as
ed
 
Pr
os
pe
cti
ve
 C
oh
or
t 
(JP
HC
) S
tu
dy
Ja
pa
n
55
.7
54
.5
18
70
,69
6
12
,38
1
30
25
50
55
++
+
9
Ch
en
 et
 al
. c
ur
re
nt
 
stu
dy
Th
e R
ot
ter
da
m
 S
tu
dy
Ne
th
er
lan
ds
63
.5
60
.8
13
.0
77
86
35
89
87
7
89
6
++
+
9
Dietary protein intake and all‑cause and cause‑specific mortality: results from the Rotterdam…
1 3
Fig. 1  Relative risks (RRs) for 
the associations between protein 
intake (highest versus lowest 
categories) with all-cause and 
cause-specific mortality. Solid 
dots denote individual HRs, 
horizontal lines demote indi-
vidual 95% CIs, open diamonds 
correspond to the pooled RRs 
including the 95% CIs, P values 
denote Pheterogeneity values, I–V 
Subtotal denotes fixed-effects 
analysis, and D + L Subtotal 
denotes random-effects analysis. 
CVD mortality cardiovascular 
mortality, RR relative risk, CI 
confidential interval. a, 59,841 
all-cause deaths among 247,863 
participants for total protein 
and all-cause mortality, 14,704 
CVD deaths among 245,222 
participants for total protein 
and CVD mortality, 21,591 
cancer deaths among 25,499 
participants for total protein and 
cancer mortality, 15,394 other 
deaths and 139,128 participants 
for total protein and other mor-
tality. b 57,288 all-cause deaths 
among 241,482 participants for 
animal protein and all-cause 
mortality, 13,552 CVD deaths 
among 242,572 participants 
for animal protein and CVD 
mortality, 15,898 cancer deaths 
among 248,618 participants 
for animal protein and cancer 
mortality, 15,394 other deaths 
and 139,128 participants for 
animal protein and other mortal-
ity. c 57,288 all-cause deaths 
among 241,482 participants 
for plant protein and all-cause 
mortality, 13,906 CVD deaths 
among 250,316 participants for 
plant protein and CVD mortal-
ity, 28,953 cancer deaths among 
248,618 participants for plant 
protein and cancer mortal-
ity, 15,394 other deaths and 
139,128 participants for plant 
protein and other mortality
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mortality, the pooled dose–response association between 
total protein intake and all-cause mortality was null, but 
with high heterogeneity  (I2 = 87.8%, Pheterogeneity = 0.004) 
(Supplemental Table 10). Estimates for animal and plant 
protein were not available in this study. After incorpo-
rating results from the study by Tharrey et al. [14] for 
animal and plant protein and CVD mortality, the results 
remained similar [e.g. for animal protein and CVD mor-
tality: per 5 E% increment, 1.08 (1.01, 1.16)] (Supple-
mental Table 10).
The appearance of funnel plots was symmetrical for 
all analyses, and Egger’s test results were not significant 
(Supplemental Figure 3), suggesting no publication bias.
Fig. 1  (continued)
Fig. 2  Combined dose–response associations between dietary pro-
tein intake with mortality (solid line) with 95% confidence intervals 
(shaded area). a The median total protein intake ranged from 11.3 E% 
through 25.0 E%. b The median animal protein intake ranged from 
4.3 E% through 20.0 E%. c The median plant protein intake ranged 
from 2.6 E% through 8.4 E%
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Discussion
Main findings
In the Rotterdam Study, we observed that higher total 
protein intake was associated with higher all-cause mor-
tality, which was mainly driven by higher animal protein 
intake and CVD mortality. Plant protein intake was not 
associated with all-cause or cause-specific mortality. 
A meta-analysis of eleven prospective cohort studies 
including the Rotterdam Study corroborated that higher 
total protein intake may increase risk of all-cause mor-
tality, driven by a harmful association between animal 
protein and CVD mortality. Furthermore, our overall 
meta-analysis also indicated that higher plant protein 
may decrease all-cause mortality and CVD mortality. 
These overall meta-analysis results were modified by 
geographical study location. As we further observed 
that the harmful associations of total and animal protein 
were mainly among the North American and European 
populations, and the inverse associations of plant protein 
were mainly among the North American and Japanese 
populations.
Interpretations of our findings
In contrast to reported beneficial short-term effects of 
dietary protein intake on weight management, and cardio-
vascular risk factors [2, 3, 41], we observed that a higher 
total protein intake was associated with higher all-cause 
mortality, which was mainly driven by a positive associa-
tion between animal protein intake and CVD mortality.
Possible mechanisms and pathways for animal pro-
tein and CVD mortality may involve the amino acids of 
animal protein (e.g. branched-chain and aromatic amino 
acids) and accompanying components of animal protein 
from animal food sources (e.g. SFA from red and pro-
cessed meat). Animal protein is relatively high in dietary 
branched-chain and aromatic amino acids, which may 
result in insulin resistance [42, 43] and overweight [43, 
44], via mammalian target of rapamycin (mTOR) path-
way [45]. These are strong risk factors for various car-
diometabolic diseases, in turn increasing CVD mortality 
risk [42]. Furthermore, the association could be fueled 
or amplified by other components in animal-based foods, 
such as SFA and sodium from red and processed meat, 
which have both been linked to higher CVD risk [11, 
46]. To investigate if the association of animal protein 
intake and CVD mortality would differ by more spe-
cific CVD causes, we further examined non-stroke CVD 
mortality and stroke mortality in the Rotterdam Study. 
We observed that the association of animal protein and 
CVD mortality was mainly driven by non-stroke CVD 
mortality, which is in line with previous studies which 
indicated a lack of association between animal protein 
intake with stroke [16, 47]. Moreover, we observed in 
subgroup analyses that these harmful associations were 
mainly observed in North American and European popu-
lations, not in Japanese populations. That could be partly 
explained by different levels and food sources of animal 
protein intake. In the North American [11] and European 
study populations [13], the major animal protein sources 
were red and processed meat; whereas in the Japanese 
study populations, population levels of animal protein 
intake were lower and the main animal protein source was 
fish [16]. Indeed, in the Rotterdam Study, we observed 
that the harmful association of animal protein intake and 
CVD mortality was mainly driven by protein from meat 
and dairy not by protein from fish and eggs. Similarly, 
Song et al. [11] also reported that the harmful associa-
tion of mainly driven by protein from red and processed 
meat not by fish and eggs among American cohorts. In 
addition to different food sources, differences in cooking 
or preparation methods may also have contributed to the 
discrepancy of the associations between the Japanese, 
North American and European populations [48, 49]. For 
plant protein, we observed inverse associations between 
plant protein intake and all-cause and CVD mortality 
in the overall meta-analysis. Overall, the difference of 
associations for animal protein and plant protein might 
be explained by their different amino acid composition. 
Unlike animal protein, plant protein is generally low in 
branched-chain acids and aromatic amino acids [5, 50], 
thereby, resulting in decreased risks of CVD [43]. In 
subgroup analyses, we observed the inverse associations 
existed in North American and Japanese populations, but 
not in European populations. This may also be explained 
by different dietary plant protein sources among differ-
ent populations. In the European populations, the main 
source was grains [42]. Among the North American pop-
ulations in the studies by Song et al. and Malik et al., the 
main plant protein sources were legumes, whole grains 
and nuts [11, 51], and in the Japanese populations in the 
study by Budhathoki et al. [16], the main source was leg-
umes. Indeed, we observed that in the Rotterdam Study 
protein from grains as the main contributor of plant pro-
tein, was not associated with all-cause and cause-specific 
mortality, yet, protein from legumes, nuts, vegetables, 
and fruits, was inversely associated with all-cause and 
cause-specific mortality. This may be explained by dif-
ferences in other components in these food groups, such 
as fibers and unsaturated fat [52].
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Overall, the evidences provided herein indicates the 
importance of specific protein sources for overall health, 
especially CVD health, and support a replacement of ani-
mal protein intake with plant protein intake. For example, 
in our meta-analysis, we observed that those in the highest 
quantile of animal protein intake, may have an averagely 
9% higher CVD mortality risk than those in the lowest 
quantile. Based on reports of the individual studies, we 
estimated that those in the highest quantile had a median 
animal protein intake of approximately 75 g/day, and those 
in the lowest quantile around 38 g/day. This suggests that a 
decrease in animal protein intake from 75 g/day (e.g. cor-
responding to around 220 g red meat/day) to 42 g/day (e.g., 
around 100 g red meat/day), may attenuate risk of CVD 
mortality by around 9%, assuming other covariates remain 
stable. However, given that the studies in our meta-anal-
ysis were mainly performed among general middle-aged 
populations, our results and public health implications can-
not be generalized to patient groups who may have other 
protein requirements and very old people. For example, 
for severely ill patients or very old people, high dietary 
protein intake may be beneficial in recovery or to prevent 
sarcopenia.
Strengths and limitations
Our study has several strengths. First, the Rotterdam Study 
analysis was based on a prospective design and included 
comprehensive assessments of cause-specific deaths. Sec-
ond, our meta-analysis is, to our knowledge, the first to 
summarize the associations of specific dietary protein 
intake with all-cause and cause-specific mortality, for 
which, we conducted not only highest versus lowest meta-
analyses, but also dose–response meta-analyses. This can 
help to quantify the associations and test the shape of these 
possible associations. Third, the meta-analysis was based 
on several prospective cohort studies across various popu-
lations from different geographical locations. Moreover, 
the combined sample size was large, and the follow-up 
period was long, resulting in a substantial number of cases. 
Additionally, the cohort studies cohort studies in the meta-
analysis were of medium to high quality, and their analy-
ses included macronutrient substitution models as well as 
adjustments for other important confounding factors, such 
as total energy, physical activity, and BMI.
We also need to acknowledge several limitations. First, 
the Rotterdam Study and most studies in the meta-analysis 
measured dietary intake data based on self-reported FFQs, 
24-h dietary recalls, or food records, for which measure-
ments errors are unavoidable (e.g. dietary under-reporting). 
However, as these methods were expected to adequately 
rank subjects according to food and nutrient intake, we 
do not expect these measurement-errors to have largely 
affected associations. Second, in all studies except one, 
dietary intake data were measured only once at baseline, 
and changes in diet over time may affect associations. How-
ever, our results were generally consistent with results from 
the only study with repeated dietary measurements [11]. 
Third, in the Rotterdam Study analysis, a weak trend of an 
association between animal protein intake and other mor-
tality might exist, but we could not further explore this 
due to limited numbers of cases for death from specific 
other causes. Fourth, we observed that the geographic 
study location modified the meta-analysis results. However, 
we could not further conduct subgroup analyses or meta-
regression to explore other potential sources of the het-
erogeneity (e.g., age and sex). For example, we could not 
explore possible sex difference. Only two studies including 
the Rotterdam Study reported sex-stratified associations. 
The Rotterdam Study analysis observed that the associa-
tion between animal protein intake and all-cause mortality, 
but not CVD mortality, differed by sex in the Rotterdam 
Study, with positive associations only in men. Only one 
other study examined sex differences for this association 
and observed null associations in both genders [11]. Fifth, 
we examined associations of protein from more specific 
food sources (e.g. protein from meat, fish, dairy, grains, 
and potatoes) with mortality in the Rotterdam Study, but 
the data for protein from more specific food sources and 
mortality to date are still limited, and we were not able to 
further meta-analyze evidence for protein from more spe-
cific food sources. Sixth, since all the studies included in 
the meta-analysis were conducted in general middle-aged 
and young-old populations (< 65 years) at baseline, our 
results may not be generalizable to populations with other 
protein requirements. Last, as a meta-analysis of observa-
tional studies, the results could be subject to residual or 
unmeasured confounding. Thus, the associations we report 
should be interpreted with caution.
In conclusion, our study provides evidence that higher 
total protein intake is associated with higher all-cause mor-
tality, primarily driven by a positive association between 
animal protein intake and CVD mortality. In contrast, 
higher plant protein intake is associated with lower all-
cause and CVD mortality. Food source and level of protein 
may play a substantial role as we observed harmful asso-
ciations of total and animal protein mainly in North Ameri-
can and European populations and beneficial associations 
of plant protein mainly in North American and Japanese 
populations. Further studies in other populations with dif-
ferent amounts and food sources of protein intakes or with 
different protein requirements are needed to improve global 
dietary recommendations and to define optimal ranges and 
sources of protein intake for different populations.
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